CT-G20

DRUG2 trials

Sponsors

Celltrion

Conditions

Cardiomyopathy, Hypertrophic ObstructiveHealthy

Phase 1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 or CT-G11 and Food Effect of CT-G20 in Human Participants

CompletedNCT03918967

CelltrionHealthy

Start: 2019-04-08End: 2020-06-06Updated: 2020-06-09

A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy

TerminatedNCT04418297

CelltrionCardiomyopathy, Hypertrophic Obstructive

Start: 2020-10-23End: 2022-11-22Updated: 2023-03-02